Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183768 · ClinicalTrials.gov registry record · Phase 3
Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users
A Phase 3 study, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 175
- Enrollment target
NCT00183768 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 175 participants.
The verdict
NCT00183768, a Phase 3 study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 175 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of combining cognitive behavioral therapy (CBT) and antidepressants in reducing HIV risk behavior and drug relapse rates in depressed intravenous drug users.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Psychopharmacology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 1999-09 |
| Est. Completion | 2003-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00183768
The ClinicalTrials.gov registry entry for NCT00183768 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT00183768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00183768 about?
NCT00183768 is a clinical study titled "Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users". This study will evaluate the effectiveness of combining cognitive behavioral therapy (CBT) and antidepressants in reducing HIV risk behavior and drug relapse rates in depressed intravenous drug users.
What is the current status of trial NCT00183768?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 175 participants. The study started on 1999-09. Estimated completion is 2003-02.
What interventions are being tested in trial NCT00183768?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Psychopharmacology (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183768?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.